Ignite Creation Date:
2024-05-06 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03611868
Status:
RECRUITING
Last Update Posted:
2024-02-01
First Post:
2018-07-27
Brief Title:
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
Sponsor:
Ascentage Pharma Group Inc
Organization:
Ascentage Pharma Group Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unresectable or Metastatic Melanoma or Advanced Solid Tumors |
| Melanoma |
| Uveal Melanoma |
| P53 Mutation |
| MDM2 Gene Mutation |
| MPNST |
| Cutaneous Melanoma |
| Mucosal Melanoma |
| Malignant Peripheral Nerve Sheath Tumors |
Keywords:
| Name | View |
|---|---|
| pembrolizumab | View |